This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Valve disease

November 15, 2023
CTSNet Congenital Editor Prof. Sameh Said spoke with Dr. Ahmad Ali Amirghofran about his pioneering method for valve construction from the right atrial appendage, demonstrated in “How to Make a Valve for the RVOT from the Right Atrial Appendage.”
October 4, 2023
A newly published review by Dr. David on aortic valve sparing operations
September 5, 2023
This video demonstrates a new modification to the periareolar approach, periareolar minimally invasive technique (PAMI).
August 4, 2023
Because of the potential risk of early structural valve deterioration, the FDA has sent notice about Abbott’s decision to stop selling and distributing Trifecta aortic surgical heart valves in the United States.
July 11, 2023
This article proposes a set of new techniques for mitral valve repair that employ a running suture rather than individual cords. They follow landmarks such as papillary muscle tips and free leaflet edge running and commissure so that there is little space left for guessing.
June 15, 2023
The authors performed a systematic review to determine whether direct oral anticoagulants (DOACs) are as safe and effective as vitamin K antagonists in the three months after bioprosthetic valve replacement.
June 1, 2023
A large RCT suggesting superiority of the transcatheter 'Alfieri' (Mitra-clip, edge to edge) repair over BMT. .
February 22, 2023
Dozens of millions of people live with RHD yet do not receive the attention they deserve. This Heart Valve Disease Awareness Day, CTSNet highlights efforts to evolve RHD from a disease of poverty to a disease of the past.
February 9, 2023
A retrospective analysis of early experience with a new approach to totally endoscopic aortic valve replacement in 266 patients showed satisfactory results, with acceptable morbidity and low mortality rates.
November 17, 2022
Researchers continue to report findings from the first genetically modified pig heart transplant into a human ten months after the surgery. Their latest study found unexpected electrocardiogram results in the patient, which the authors say did not contribute to heart failure.